Paradigm to market Lace’s glaucoma detection device

Lace’s Glaid is a revolutionary diagnostic device that utilizes Pattern Electroretinogram (PERG) to provide a visual stimulus that generates electrical responses of the retina to measure the physical condition of the retina’s ganglion cells.

Raymond Cannefax, CEO of Paradigm Medical, said: “The Glaid device is believed to be the fastest method of testing for retinal ganglion cell loss. The Glaid not only measures dead and living ganglion cells, but also detects ailing ganglion cells. Due to the device’s ability to detect dying ganglion cells, in most cases the viability of these cells can be fully restored with treatment.”